Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials

被引:2
|
作者
Silverii, Giovanni Antonio [1 ,3 ]
Marinelli, Christian [1 ]
Mannucci, Edoardo [1 ]
Rotella, Francesco [2 ]
机构
[1] Florence Univ, Expt & Clin Biomed Sci Dept, Diabetol Unit, Florence, Italy
[2] Florence Univ, Hlth Sci Dept, Psychiat Unit, Florence, Italy
[3] Univ Florence, Expt & Clin Biomed Sci Mario Serio Dept, Largo Brambilla 3, I-50134 Florence, Italy
来源
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 06期
关键词
QUALITY;
D O I
10.1111/dom.15538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:2505 / 2508
页数:4
相关论文
共 50 条
  • [31] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Patients With or Without Heart Failure: A Meta-Analysis of Randomized Control Trials
    Obata, Shota
    Miyamoto, Yoshihisa
    Slipczuk, Leandro
    Takagi, Hisato
    Kuno, Toshiki
    CIRCULATION, 2022, 146
  • [32] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
    Monami, Matteo
    Dicembrini, Ilaria
    Omarchionni, Niccolo
    Rotella, Carlo M.
    Mannucci, Edoardo
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [33] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    DIABETES, 2011, 60 : A295 - A295
  • [34] Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials
    Adamou, Anastasia
    Barkas, Fotios
    Milionis, Haralampos
    Ntaios, George
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (08) : 876 - 887
  • [35] An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
    Riccardo De Giorgi
    Ana Ghenciulescu
    Oliwia Dziwisz
    Maxime Taquet
    Amanda I. Adler
    Ivan Koychev
    Rachel Upthegrove
    Marco Solmi
    Robert McCutcheon
    Toby Pillinger
    Philip J. Cowen
    Catherine J. Harmer
    Nature Mental Health, 2025, 3 (3): : 354 - 373
  • [36] Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Liu, Huixing
    Fu, Di
    Peng, Daoquan
    CLINICAL THERAPEUTICS, 2023, 45 (01) : 17 - 30
  • [37] Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
    Mantovani, Alessandro
    Petracca, Graziana
    Beatrice, Giorgia
    Csermely, Alessandro
    Lonardo, Amedeo
    Targher, Giovanni
    METABOLITES, 2021, 11 (02) : 1 - 13
  • [38] Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials
    Hosseinpour, Alireza
    Sood, Aayushi
    Kamalpour, Jahangir
    Zandi, Ehsan
    Pakmehr, Seyedabbas
    Hosseinpour, Hamidreza
    Sood, Akshit
    Agrawal, Ankit
    Gupta, Rahul
    CLINICAL CARDIOLOGY, 2024, 47 (07)
  • [39] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [40] A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
    Hu, En-Hao
    Tsai, Ming-Lung
    Lin, Yuan
    Chou, Tien-Shin
    Chen, Tien-Hsing
    MEDICINA-LITHUANIA, 2024, 60 (03):